跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,572 条关于
“legal blindness”
全部
1,572
临床试验
232
药物
1
机构
5
资讯
1,334
去年
Gildeuretinol Shows Promise in Slowing Stargardt Disease Progression
9个月前
GenSight Biologics Secures French Regulatory Approvals for GS010/LUMEVOQ Gene Therapy in Rare Blindness Disease
10个月前
GenSight Biologics Secures FDA Authorization for Expanded Access Treatment of Rare Blinding Disease
去年
CDR-Life and Boehringer Ingelheim's Geographic Atrophy Treatment Advances to Phase 2 Clinical Trials
11个月前
FDA Grants Breakthrough Therapy Designation to Nacuity's NPI-001 for Retinitis Pigmentosa Treatment
去年
Astellas Seeks First Japanese Approval for Geographic Atrophy Treatment with Avacincaptad Pegol
去年
GenSight Biologics Successfully Transfers LUMEVOQ Manufacturing to Catalent for LHON Gene Therapy
11个月前
Abeona Therapeutics' ABO-503 Gene Therapy Selected for FDA's Rare Disease Endpoint Advancement Pilot Program
去年
Oculis Accelerates Enrollment in Phase 3 DME Trial for OCS-01 Eye Drops
10个月前
ONL Therapeutics Initiates Phase 2 GALAXY Trial for Xelafaslatide in Geographic Atrophy
第 1 页,共 134 页
上一页
下一页